glp 1 class of drugs GLP-1 Agonists for Weight Loss: Safe or Risky? The GLP-1 Agonists and Obesity:
Description
[DOI] [PubMed] [Google Scholar] 41.Reid T

doi: 10.1161/JAHA.119.012244

A critical consideration is that diabetes itself substantially increases gastroparesis riskaffecting up to 5% of patients with type 1 diabetes and 1% with type 2 diabetes

Lancet 373 , 438439 (2009)

This classification means the product is intended for in vitro laboratory research and is not manufactured, tested, or quality-controlled to pharmaceutical standards
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)